Placenta
Volume 30, Issue 3 , Pages 250-255 , March 2009

Novel Splice Variants of sFlt1 are Upregulated in Preeclampsia

  • M. Heydarian

      Affiliations

    • Department of Biochemistry and Molecular Biology, George Washington University, Washington, DC, USA
    • ,
  • T. McCaffrey

      Affiliations

    • Department of Biochemistry and Molecular Biology, George Washington University, Washington, DC, USA
    • ,
  • L. Florea

      Affiliations

    • Department of Computer Science, George Washington University, Washington, DC, USA
    • ,
  • Z. Yang

      Affiliations

    • Department of Biochemistry and Molecular Biology, George Washington University, Washington, DC, USA
    • ,
  • M.M. Ross

      Affiliations

    • The Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA
    • ,
  • W. Zhou

      Affiliations

    • The Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA
    • ,
  • S.E. Maynard

      Affiliations

    • Department of Biochemistry and Molecular Biology, George Washington University, Washington, DC, USA
    • Department of Medicine, George Washington University, Washington, DC, USA
    • Corresponding Author InformationCorrespondence to: Sharon E. Maynard, George Washington University, School of Medicine, Department of Medicine, 2150 Pennsylvania Avenue NW, Suite 1-200, Washington, DC 20037, USA. Tel.: +1 202 741 2283; fax: +1 202 741 2285.

,Accepted 9 December 2008.

References 

  1. Walker JJ. Pre-eclampsia. Lancet. 2000;356(9237):1260–1265
  2. ACOG Practice Bulletin . Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 2002;77(1):67–75
  3. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol. 1992;99(7):547–553
  4. Mackay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol. 2001;97(4):533–538
  5. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?. J Clin Invest. 1997;99(9):2152–2164
  6. Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol. 2002;160(4):1405–1423
  7. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989;161(5):1200–1204
  8. Ferris TF. Pregnancy, preeclampsia, and the endothelial cell. N Engl J Med. 1991;325(20):1439–1440
  9. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649–658
  10. Lu F, Longo M, Tamayo E, Maner W, Al-Hendy A, Anderson GD, et al. The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am J Obstet Gynecol. 2007;196(4):396;e1–e7
  11. Gilbert JS, Babcock SA, Granger JP. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension. 2007;50(6):1142–1147
  12. Makris A, Thornton C, Thompson J, Thomson S, Martin R, Ogle R, et al. Uteroplacental ischemia results in proteinuric hypertension and elevated sFlt-1. Kidney Int. 2007;71(10):977–984
  13. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672–683
  14. Vatten LJ, Eskild A, Nilsen TI, Jeansson S, Jenum PA, Staff AC. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia. Am J Obstet Gynecol. 2007;196(3):239;e1–e6
  15. Kim SY, Ryu HM, Yang JH, Kim MY, Han JY, Kim JO, et al. Increased sFlt-1 to PlGF ratio in women who subsequently develop preeclampsia. J Korean Med Sci. 2007;22(5):873–877
  16. Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, Weisstuch J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med. 2008;358(11):1129–1136
  17. Kendall RL, Thomas KA. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA. 1993;90(22):10705–10709
  18. Florea L, Hartzell G, Zhang Z, Rubin GM, Miller W. A computer program for aligning a CDNA sequence with a genomic DNA sequence. Genome Res. 1998;8(9):967–974
  19. Florea L, Di Francesco V, Miller J, Turner R, Yao A, Harris M, et al. Gene and alternative splicing annotation with air. Genome Res. 2005;15(1):54–66
  20. Camerini Serena, Polci Maria L, Liotta Lance A, Petricoin Emanuel F, Zhou Weidong. A method for the selective isolation and enrichment of carrier protein-bound low-molecular weight proteins and peptides in the blood. Proteomics Clin Appl. 2007;1(2):176–184
  21. Luchini A, Geho DH, Bishop B, Tran D, Xia C, Dufour RL, et al. Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation. Nano Lett. 2008;8(1):350–361
  22. Thomas CP, Andrews JI, Liu KZ. Intronic polyadenylation signal sequences and alternate splicing generate human soluble Flt1 variants and regulate the abundance of soluble Flt1 in the placenta. FASEB J. 2007;21(14):3885–3895
  23. Sela S, Itin A, Natanson-Yaron S, Greenfield C, Goldman-Wohl D, Yagel S, et al. A novel human-specific soluble vascular endothelial growth factor receptor 1: cell type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia. Circ Res. 2008;102(12):1566–1574
  24. Wain HM, Bruford EA, Lovering RC, Lush MJ, Wright MW, Povey S. Guidelines for human gene nomenclature. Genomics. 2002;79(4):464–470
  25. Hertig A, Berkane N, Lefevre G, Toumi K, Marti HP, Capeau J, et al. Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia. Clin Chem. 2004;50(9):1702–1703
  26. Chung JY, Song Y, Wang Y, Magness RR, Zheng J. Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies. J Clin Endocrinol Metab. 2004;89(5):2484–2490
  27. Tsatsaris V, Goffin F, Munaut C, Brichant JF, Pignon MR, Noel A, et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab. 2003;88(11):5555–5563
  28. Lindheimer MD, Umans JG. Explaining and predicting preeclampsia. N Engl J Med. 2006;355(10):1056–1058

PII: S0143-4004(08)00422-0

doi: 10.1016/j.placenta.2008.12.010

Placenta
Volume 30, Issue 3 , Pages 250-255 , March 2009

Article Tools

* Image Usage & Resolution